Eftychia Kontidou
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Targeting Arginase 1 but Not Arginase 2 Protects from Myocardial Ischemia-Reperfusion Injury via Nitric Oxide Signaling by Red Blood Cells in Type 2 Diabetes.
Journal: Antioxidants (Basel, Switzerland)
Published: November 21, 2025
microRNA-210 in red blood cells differentially regulates vascular endothelial function between type 1 and type 2 diabetes.
Journal: Physiological reports
Published: November 21, 2025
Red blood cells as potential materials for microRNA biomarker study: overcoming heparin-related challenges.
Journal: American journal of physiology. Heart and circulatory physiology
Published: October 18, 2024
Red blood cells from patients with ST-elevation myocardial infarction and elevated C-reactive protein levels induce endothelial dysfunction.
Journal: American journal of physiology. Heart and circulatory physiology
Published: October 11, 2024
Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase.
Journal: Clinical science (London, England : 1979)
Published: March 12, 2024
Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes.
Journal: The Journal of clinical investigation
Published: March 08, 2024
miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction.
Journal: British journal of pharmacology
Published: February 06, 2024
Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: March 16, 2023
Extracellular vesicles and their non-coding RNA cargos: Emerging players in cardiovascular disease.
Journal: The Journal of physiology
Published: June 15, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026